What did @f.est_ actually say?
Honestly, not much, at least verbally. The transcript is a repeated phrase: "I'm not going to be a dreamer." That's it. The video is a celebration post, tagged with #lafest and #weightloss, set in the GLP-1 category. So the "claim" here isn't really spoken, it's implied. The implication is that GLP-1 medication worked for her, and she's living proof.
That kind of testimonial, a happy dance with a weight loss hashtag, carries real persuasive weight with 65,500 viewers even when zero medical claims are spoken aloud. The message lands anyway: she took something, she lost weight, and now she's dancing. That's the claim we're actually fact-checking.
Does the science back this up?
GLP-1 receptor agonists do produce meaningful weight loss in a significant portion of people who use them, so the general premise of the video, that these drugs work, is supported by solid evidence. But "it worked for me" is not the same as "it will work for you," and that gap matters.
The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) found that semaglutide 2.4 mg produced an average body weight reduction of 14.9% over 68 weeks compared to 2.4% with placebo. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide produced up to 22.5% mean weight reduction at the highest dose. Those are population averages. Individual responses vary considerably, and a meaningful percentage of patients are low or non-responders.
Side effect profiles are also real. Nausea, vomiting, and gastrointestinal discomfort affect a substantial portion of users, particularly early in treatment. A happy dance video does not convey that context.
What did they get wrong (or right)?
To be fair to @f.est_, she didn't make any specific medical claims. She said "I'm not going to be a dreamer" while apparently celebrating weight loss results. She didn't recommend a dose, name a drug, or tell anyone what to do. That's actually more responsible than a large portion of the GLP-1 content circulating on TikTok right now.
What she got right, implicitly, is the emotional reality of this medication category. For many people, GLP-1 drugs represent a genuine shift after years of failed attempts at weight management. The psychological dimension of that is not nothing.
What's missing, through no malicious intent, is any acknowledgment that this is a prescription medication with side effects, contraindications, and real costs. Celebratory content with 65K views shapes expectations. Viewers who see the dance may not see the weeks of nausea that sometimes precede it. That asymmetry in information is the actual problem here, not anything the creator said wrong.
What should you actually know?
GLP-1 receptor agonists are legitimate, FDA-approved medications for chronic weight management and type 2 diabetes, depending on the specific agent and indication. They are not magic, and they are not appropriate for everyone.
A few things worth knowing before a video like this shapes your expectations:
- Results vary significantly. Population-level trial data shows strong average outcomes, but individual response is not guaranteed.
- These are chronic medications. The STEP 4 trial (Rubino et al., 2021, JAMA) showed that people who discontinued semaglutide regained a substantial portion of lost weight within a year. Stopping is not a neutral act.
- Compounded semaglutide is not the same product as FDA-approved Wegovy or Ozempic. Do not assume equivalency in potency, purity, or safety.
- Side effects are common. GI symptoms affect a large number of users, and rare but serious risks, including pancreatitis and thyroid concerns, are documented in prescribing information.
- Access requires a clinical evaluation. No responsible provider should prescribe these medications without a proper intake, medical history review, and ongoing monitoring.
The dance is cute. The drug category is legitimate. But 65K people deserve more than a vibe, and if this content inspires someone to seek GLP-1 treatment, they should do it through a regulated clinical pathway, not because someone looked happy on TikTok.